Research
New cell therapy shows promise with ARDS patients
Initial trial suggests invariant natural killer cell therapy improves survival.
Do you have memories of working in Cambridge technology? The Cambridge History of Innovation Project (CHIP) needs your help
The Cambridge History of Innovation Project (CHIP) is creating a new public archive of Cambridge technology from the Cambridge Scientific Instrument Company (1881) to more recent times. Our team, who are based at the UL, would love to hear about your memories of Cambridge technology i...
Maxion Therapeutics welcomes Dr Arndt Schottelius as new CEO
Maxion Therapeutics, the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announces that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to i...
Study estimates number of patients for potential new Alzheimer’s disease treatments
Clinical researchers at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) and South London and Maudsley NHS Foundation Trust have collaborated to model how many patients might receive new treatments for Alzheimer’s disease, currently under review. ...
Gene-editing offers hope for people with hereditary disorder
A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a breakthrough gene-editing therapy, according to the lead researcher. ...
Celebrating International Women’s Day at Cambridge Judge
Join The Wo+Men’s Leadership Centre at Cambridge Judge Business School on 8 March 2024 as we celebrate International Women’s Day. The evening offers an exciting schedule of talks, panel discussions and our third Professor Sucheta Nadkarni Research Seminar. ...
Profit warnings from UK-listed companies in the East of England at highest level since 2020 Covid 19 pandemic
Listed companies in the East of England issued five profit warnings in Q4 2023, the highest quarterly total since the Covid-19 pandemic in 2020 according to the latest EY-Parthenon Profit Warnings report. ...
Queensgate awarded funding for fourth research project with NPL
Queensgate, a brand of Prior Scientific, has won funding from Innovate UK, the UK’s innovation agency, for a fourth nanopositioning research project as part of Analysis for Innovators (A4I) program (Round 11). ...
Leading UK and South African genomics labs unite to take disease surveillance beyond Covid
Genomic surveillance laboratories in the UK and South Africa, renowned for their work identifying new variants during the COVID-19 pandemic, have joined forces to identify emerging threats from infectious diseases. ...
Don't miss your chance to enter the Cambridge Independent Science and Technology Awards 2024
The deadline is January 31.